'Planned 49% limit' for NHS private patients in England

27 December 2011
By Helen Briggs Health editor, BBC News website


A recent revision to the ongoing health bill will allow foundation hospitals to raise 49% of funds through non-NHS work if the bill gets through Parliament.

Most foundation trusts are now limited to a private income of about 2%.

The Health Secretary says the move will benefit NHS patients but Labour claimed it could lead to longer waiting lists.

The amendment to a clause of the Health and Social Care Bill was made shortly before Christmas by Health Minister Earl Howe.

Commenting on the move, Health Secretary Andrew Lansley said lifting the private income cap for foundation hospitals would directly benefit NHS patients.

"If these hospitals earn additional income from private work that means there will be more money available to invest in NHS services," he said in a statement.

"Furthermore services for NHS patients will be safeguarded because foundation hospitals' core legal duty will be to care for them."

But Labour's shadow Health Secretary Andy Burnham claimed the move could mean longer waits for NHS patients.

He said: "This surprise move, sneaked out just before Christmas, is the clearest sign yet of David Cameron's determination to turn our precious NHS into a US-style commercial system, where hospitals are more interested in profits than people.

"With NHS hospitals able to devote half of their beds to private patients, people will begin to see how our hospitals will never be the same again if Cameron's Health Bill gets through Parliament."

Critical services

A cap on the amount of income hospitals can raise from private patients was put in place by Labour in 2003, amid political controversy over the setting up of foundation hospitals, which have more freedom to decide how their services are run. All NHS hospitals are set to become foundation hospitals by 2014.

The cap has prevented hospitals from expanding their private work beyond the proportion earned in 2002. It varies from hospital to hospital, but is limited to about 2% in most hospitals.

In a small number of specialist hospitals, such as the Royal Marsden, the limit is set much higher, at around 30%. Health secretary Andrew Lansley has long said he will abolish the cap but it has been unclear how much private work would be allowed.

Proponents of the move have pointed out that the Royal Marsden is rated one of the best NHS providers while taking up to around a third of its income from private activity.

But critics are concerned that NHS patients would get a poor deal under the proposals, as foundation trusts with large financial deficits seek to take on more private work.

Dr Peter Carter, chief executive and general secretary of the Royal College of Nursing (RCN), said it was "a seriously worrying development".

"At a time when the health service has to make significant efficiency savings, it is only natural, that given the option, providers will look to maximise their income through private patients," he said.

"This will undoubtedly lead to a situation whereby those who can afford to pay will get faster access to better treatment, with increased waiting times and a decrease in quality for NHS patients."

He said existing NHS providers could be left to deliver critical services, which are the most expensive and challenging to run.

He added: "Really, it doesn't get much more serious than this; the Government has consistently assured us that the NHS is safe in their hands, but if allowed to go ahead, the removal of the cap could lead to the fundamental erosion of key NHS principles.

"The very heart of these principles being that access to care should be on the basis of clinical need, regardless of ability to pay."

Dual role

But the chief executive of the health thinktank, the King's Fund, Chris Ham said hospitals had generated funds from private patients for many years, and it was possible to provide high quality care to both NHS and private patients in the same hospital.

"The cap is only a significant consideration for a minority of hospitals," he said.

"These hospitals should report annually on how they are ensuring NHS patients do not lose out if the cap is either removed or at a relatively high proportion of income."



Go Back



30 Aug--1 Sept 2024
Details >>


16-17 Sept 2023
Details >>

30 Apr & 1 May 2023
FPMPAM / AMAM Joint ASM 2023
Details >>


27 Oct 2022
JA Assure Partners FPMPAM To Offer Professional Indemnity Insurance Platform To All Medical Professionals Of FPMPAM
Details >>


12 Oct 2022
Covid Fight: Private docs played key role
Details >>


17 Nov 2020
BIOLOGIC ADVISORY GROUP MY: Consensus Guidelines in Usage of Biologics in Dermatology during Covid-19 Pandemic
Details >>

30 Jun 2020
MOH Circular - Quarantine Process for General Practitioners
Details >>


31 Jan 2020
Handbook of 2019-nCoV Pneumonia Control and Prevention
Details >>


31 Jan 2020
Edaran Kemaskini Guidelines on 2019 Novel Coronavirus Management in Malaysia
Details >>


12 Aug 2018
Implementation of Data Breach Notification
Details >>

25 April 2018
Guidelines on Continuing Professional Development (CPD) for Medical Practitioners In Malaysia
Download >>

8 Mar 2018
Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>


Latest Newsletter

go to newsletter section



Resources / Links

Specialist Medical Practitioners Continuing Professional Development (CPD) Policies and Guidelines
Read >>


Joint Integrated Healthcare Committee (JIHC) Term Sheet
Click here >>


Joint Integrated Healthcare Committee (JIHC) Terms of Reference
Click here >>


National Pharmaceutical Regulatory Agency
Click here >>


NPRA: Reporting medicinal problems
Click here >>


Makluman Kontraindikasi Penggunaan Ubat Yang Mengandungi Codeine Untuk Kanak-Kanak Beumur Bawah 12 Tahun Dan Ibu Yang Menyusu Susulan Risiko Respiratory Depression
Click here >>


Peringatan: Langkah-Langkah Pengurangan Risiko Bagi Kesan Advers Kulit Tang Serius Susulan Penggunaan Allopurinol
Click here >>


Guide for HCP >>
Patient Information >>
Sodium Valproate (Guide for HCP) >>


NDST Report 2011
Click here >>


Garis Panduan Pemantauan Keselamatan Produk ESAs dan Pelaporan Kesan Advers PRCA
Click here >>


Report On Suspected Adverse Drug Reactions
Click here >>


MADRAC Newsletter Vol 26 Issue 2 / 2018
Read >>


MADRAC KE 146 - Traditional Medicine found Adulterated
Read >>

BPFK website: Cancellation of Registered Traditional Products / Notified Cosmetics
Read >>

Pharmacy Services Division: List of Adulterated Products
Read >>


Pharmacy Services Division: Press Releases
Read >>